Effect of Repeatedl-DOPA, Bromocriptine, or Lisuride Administration on Preproenkephalin-A and Preproenkephalin-B mRNA Levels in the Striatum of the 6-Hydroxydopamine-Lesioned Rat

This publication has 87 references indexed in Scilit:

• Induction of dopamine D ₃ receptor expression as a mechanism of behavioral sensitization to levodopa
  Proceedings of the National Academy of Sciences, 1997
• Prefrontal Corticostriatal Afferents Maintain Increased Enkephalin Gene Expression in the Dopamine‐denervated Rat Striatum
  European Journal of Neuroscience, 1994
• Naloxone reverses L-DOPA induced overstimulation effects in a Parkinsons disease animal model analogue
  Life Sciences, 1991
• Reduction of Dopamine Receptor Activity Differentially Alters Striatal Neuropeptide mRNA Levels
  Published by Springer Nature ,1987
• Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA
  European Journal of Pharmacology, 1986
• Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding
  Brain Research, 1986
• The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species
  Nucleic Acids Research, 1984
• Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity
  Neuroscience Letters, 1983
• LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE
  The Lancet, 1978
• Bromocriptine in Parkinsonism
  BMJ, 1974